A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2019; you can also visit the original URL.
The file type is application/pdf
.
Stability of Reconstituted and Diluted Mitomycin C Solutions in Polypropylene Syringes and Glass Vials
2016
Pharmaceutical Technology in Hospital Pharmacy
Abstract: Mitomycin C (MMC) is widely used in treatment of non-muscle invasive bladder cancer at a 1 mg/mL concentration, by intravesical instillation. MMC is also used as an ophthalmic procedure in glaucoma care mostly with 0.2 mg/mL concentration. To accelerate syringes provision, it could be interesting to demonstrate the stability of the drug, in order to be able to prepare the chemotherapeutic drug several hours before the chemotherapy administration.: A stability indicating HPLC-UV method
doi:10.1515/pthp-2016-0012
fatcat:ljbtqr6h6zhyfba2xngc6lwwwi